Page last updated: 2024-10-24

candesartan and Allergic Encephalomyelitis

candesartan has been researched along with Allergic Encephalomyelitis in 2 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, X1
Namekata, K1
Kimura, A1
Harada, C1
Harada, T1
Lanz, TV1
Ding, Z1
Ho, PP1
Luo, J1
Agrawal, AN1
Srinagesh, H1
Axtell, R1
Zhang, H1
Platten, M1
Wyss-Coray, T1
Steinman, L1

Other Studies

2 other studies available for candesartan and Allergic Encephalomyelitis

ArticleYear
The Renin-Angiotensin System Regulates Neurodegeneration in a Mouse Model of Optic Neuritis.
    The American journal of pathology, 2017, Volume: 187, Issue:12

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Encephalomyeli

2017
Angiotensin II sustains brain inflammation in mice via TGF-beta.
    The Journal of clinical investigation, 2010, Volume: 120, Issue:8

    Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Chronic Disease; Encep

2010